SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 47 filers reported holding SIGILON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $9,645,480 | +165.7% | 10,370,369 | 0.0% | 0.38% | +223.3% |
Q4 2022 | $3,629,629 | -30.0% | 10,370,369 | 0.0% | 0.12% | -46.8% |
Q3 2022 | $5,185,000 | -39.8% | 10,370,369 | 0.0% | 0.22% | -32.7% |
Q2 2022 | $8,608,000 | -43.5% | 10,370,369 | 0.0% | 0.32% | -9.5% |
Q1 2022 | $15,245,000 | -46.7% | 10,370,369 | 0.0% | 0.36% | -19.2% |
Q4 2021 | $28,622,000 | -51.2% | 10,370,369 | 0.0% | 0.44% | -27.9% |
Q3 2021 | $58,592,000 | -47.3% | 10,370,369 | 0.0% | 0.61% | -56.8% |
Q2 2021 | $111,274,000 | -52.0% | 10,370,369 | 0.0% | 1.42% | -61.7% |
Q1 2021 | $231,778,000 | -53.5% | 10,370,369 | 0.0% | 3.71% | -59.1% |
Q4 2020 | $498,089,000 | – | 10,370,369 | – | 9.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|